GUGLIESI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.390
EU - Europa 2.236
AS - Asia 1.250
AF - Africa 79
SA - Sud America 43
OC - Oceania 23
Totale 7.021
Nazione #
US - Stati Uniti d'America 3.348
IT - Italia 867
CN - Cina 431
SG - Singapore 291
IE - Irlanda 256
SE - Svezia 235
AT - Austria 158
DE - Germania 136
GB - Regno Unito 110
FR - Francia 101
KR - Corea 90
FI - Finlandia 85
UA - Ucraina 76
JP - Giappone 71
HK - Hong Kong 64
ID - Indonesia 63
VN - Vietnam 60
IN - India 48
SN - Senegal 48
BE - Belgio 42
PL - Polonia 41
CA - Canada 40
TR - Turchia 28
NL - Olanda 27
SA - Arabia Saudita 27
TW - Taiwan 23
GR - Grecia 20
AU - Australia 18
DK - Danimarca 17
BR - Brasile 15
IL - Israele 15
ES - Italia 13
CO - Colombia 12
UG - Uganda 12
NO - Norvegia 11
PK - Pakistan 11
IR - Iran 10
AR - Argentina 8
CH - Svizzera 8
RU - Federazione Russa 8
HR - Croazia 7
PH - Filippine 6
TN - Tunisia 6
EC - Ecuador 5
NZ - Nuova Zelanda 5
IQ - Iraq 4
LU - Lussemburgo 3
RO - Romania 3
TH - Thailandia 3
ZA - Sudafrica 3
BD - Bangladesh 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
ET - Etiopia 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZM - Zambia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GH - Ghana 1
IS - Islanda 1
LB - Libano 1
MA - Marocco 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PR - Porto Rico 1
YE - Yemen 1
Totale 7.021
Città #
Chandler 679
Dublin 253
Singapore 240
Beijing 160
Fairfield 150
Vienna 149
Houston 143
Torino 137
Ann Arbor 119
Sovicille 115
Ashburn 96
Nyköping 95
Turin 88
Woodbridge 83
Jacksonville 82
Wilmington 75
Dearborn 70
Jakarta 63
Cambridge 60
Princeton 60
Villeurbanne 58
Medford 57
Seattle 57
Pisa 49
Guangzhou 46
Redwood City 45
Dong Ket 44
Fremont 38
Santa Clara 36
Boston 35
New York 35
Warsaw 33
Rome 32
Shanghai 29
Milan 28
Boardman 27
Los Angeles 27
Washington 24
Pittsburgh 21
Brussels 19
Jeddah 17
Lappeenranta 17
Nanjing 17
Taipei 17
San Mauro Torinese 16
Gongju 15
Norwalk 15
Orange 15
Florence 14
San Diego 14
Helsinki 13
Rochester 13
Aarhus 12
Baltimore 12
Hebei 12
Kampala 12
Maddaloni 12
Bogotá 11
Munich 11
Piemonte 11
Dallas 10
Hefei 10
London 10
Philadelphia 10
Thebes 10
Seoul 9
Tokyo 9
Toronto 9
Birmingham 8
Istanbul 8
Phoenix 8
Tel Aviv 8
Central 7
Chicago 7
Hangzhou 7
Hanover 7
Ipswich 7
Kahramanmaraş 7
Oslo 7
Alessandria 6
Antwerp 6
Brescia 6
Falls Church 6
Fort Worth 6
Jerusalem 6
Kunming 6
Novara 6
Padova 6
San Francisco 6
Wuhan 6
Berlin 5
Bethesda 5
Bologna 5
Changsha 5
Des Moines 5
Fossano 5
Galveston 5
Gwanak-gu 5
Hong Kong 5
Lahore 5
Totale 4.207
Nome #
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 318
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 296
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 234
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 221
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 184
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 180
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 179
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 178
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 172
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 164
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 158
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 147
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 141
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 140
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 131
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 128
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 127
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 121
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 118
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 114
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 109
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 105
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 105
Where do we stand after decades of studying human cytomegalovirus? 105
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 105
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 103
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 98
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 96
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 91
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 88
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 88
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 86
Tuning the Orchestra: HCMV vs. Innate Immunity. 85
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 81
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 80
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 79
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 78
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 76
Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. 76
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 74
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 74
The interferon-inducible IFI16 gene acts as a restriction factor for human citomegalovirus replication 73
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 70
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 70
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 68
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 68
The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. 67
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 66
Detection of IFI16 in body fluids 65
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene 63
Targeting PAD-mediated citrullination to treat human papillomavirus infections 63
Biotechnology, Industry and Research in Piemonte from 1990 to 2003 : an update 61
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 61
45th International Herpesvirus Workshop 61
Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha 59
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 58
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 55
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 55
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 54
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding 53
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 49
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 48
50° Congresso Nazionale della Società Italiana di Microbiologia 45
Targeting PAD-mediated citrullination to treat human papillomavirus infections 45
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 44
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 42
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 36
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 35
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 32
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 32
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 30
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 27
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 25
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 24
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 23
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 23
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 22
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 19
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 16
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 13
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 12
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 11
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 11
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 11
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 8
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection 4
Totale 7.210
Categoria #
all - tutte 20.911
article - articoli 0
book - libri 0
conference - conferenze 12.539
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020630 0 0 0 81 37 149 78 45 66 64 46 64
2020/2021726 53 42 32 41 62 57 83 52 60 88 42 114
2021/2022835 65 22 53 82 35 30 32 35 35 63 234 149
2022/20231.853 99 109 29 237 201 423 91 152 268 55 89 100
2023/20241.039 142 154 74 51 90 105 49 68 22 65 82 137
2024/2025636 83 267 222 64 0 0 0 0 0 0 0 0
Totale 7.210